Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
11/19/2003 | EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
11/19/2003 | EP0991624B1 Phenylalkyl derivatives with thrombin-inhibiting effect |
11/19/2003 | EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
11/19/2003 | EP0914111B1 Prevention and treatment of cachexia and anorexia |
11/19/2003 | EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
11/19/2003 | EP0733066B1 Pretargeting methods and compounds |
11/19/2003 | CN1457257A Extended native chemical ligation |
11/19/2003 | CN1456561A Preparations of leucovorin and its carbonates |
11/19/2003 | CN1456287A Preparation of Zengkangning tablets against leukopenia |
11/19/2003 | CN1456263A Fresh motherwort juice-oral liquid preparing method |
11/19/2003 | CN1456257A Fresh motherwort particle preparing method |
11/19/2003 | CN1456256A Compound pseudo-ginseng preparing method |
11/19/2003 | CN1456254A Preparation of immunoregulation effervescent tablets |
11/19/2003 | CN1456253A Fresh motherwort tablet preparing method |
11/19/2003 | CN1456251A Fresh motherwort pulp preparing method |
11/19/2003 | CN1456229A Preparation of donkey hide gelatin effervescent granules for nourishing blood |
11/19/2003 | CN1456198A Angong hemostatics |
11/19/2003 | CN1456196A Yunnan Hongyao extractives and application thereof |
11/19/2003 | CN1456173A High-efficiency fast styptic |
11/19/2003 | CN1456163A Oral medicine of leucovocin calcium and its preparing method |
11/19/2003 | CN1456162A Injection of leucovorin calcium and its preparing method |
11/19/2003 | CN1456154A Method for curing sepsis |
11/19/2003 | CN1127983C Inmunization adjusting anti-inflamation agent |
11/18/2003 | US6649640 Isoxazole compositions useful as inhibitors of ERK |
11/18/2003 | US6649636 Cyclooxygenase inhibitors |
11/18/2003 | US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
11/18/2003 | US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
11/18/2003 | US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia |
11/18/2003 | US6649613 Diacylhydrazine derivatives |
11/18/2003 | US6649604 Analgesics; antidiabetic agents; antiinflamamtory agents |
11/18/2003 | US6649600 2,6-Dioxo or dithioxy-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo derivatives; highly potent and selective diuretics |
11/18/2003 | US6649388 Polypeptides derived from JNK3 |
11/18/2003 | US6649386 Stability; for reconstitution with water; antihemophilic factor; blood factor IX |
11/18/2003 | US6649375 Adenoviral vectors for enhanced gene expression |
11/18/2003 | US6649339 Screening for the presence of a parvovirus genome equivalent using nucleic acid amplification; purification |
11/18/2003 | US6649172 5-(p-carboxybenzyloxy)-2-oxybenzaldehyde derivatives; vaccine adjuvants |
11/18/2003 | CA1341447C Mutant t-pa with kringle replacement |
11/18/2003 | CA1341446C Tissue plasminogen activator analogs having modified growth factor domains |
11/17/2003 | CA2429097A1 Composition of solutions for organ protection |
11/14/2003 | CA2428516A1 Slowly digestible starch product |
11/13/2003 | WO2003093465A1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS |
11/13/2003 | WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants |
11/13/2003 | WO2003093313A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein |
11/13/2003 | WO2003093297A2 Protein kinase modulators and methods of use |
11/13/2003 | WO2003093254A1 Semicarbazide derivatives for combating thromboembolic diseases |
11/13/2003 | WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
11/13/2003 | WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
11/13/2003 | WO2003093235A1 Carboxylic acid amides |
11/13/2003 | WO2003093234A1 Melanocortin receptor ligands |
11/13/2003 | WO2003092767A2 A method for inhibiting platelet aggregation |
11/13/2003 | WO2003092741A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis |
11/13/2003 | WO2003092740A1 Non-viral gene delivery system |
11/13/2003 | WO2003092731A1 Stabilised solid compositions of modified factor vii |
11/13/2003 | WO2003092721A1 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes |
11/13/2003 | WO2003092720A1 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes |
11/13/2003 | WO2003092715A2 Proteins involved in the regulation of energy homeostasis |
11/13/2003 | WO2003092690A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
11/13/2003 | WO2003092673A1 Use of epa and dha in secondary prevention |
11/13/2003 | WO2003092660A1 Monocompartment osmotic controlled drug delivery system |
11/13/2003 | WO2003092605A2 Protease inhibitors |
11/13/2003 | WO2003092602A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
11/13/2003 | WO2003092588A2 4-azasteroid derivatives as androgen receptor modulators |
11/13/2003 | WO2003053966A3 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists |
11/13/2003 | WO2003042113A8 Production of cell suspensions |
11/13/2003 | WO2003031407A3 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS |
11/13/2003 | WO2003030944A3 Inhibition of stat-1 |
11/13/2003 | WO2003012111A3 Conjugates for the modulation of immune responses |
11/13/2003 | WO2003010281A3 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
11/13/2003 | WO2003009778A3 Methods and devices for delivery of therapeutic capable agents with variable release profile |
11/13/2003 | WO2002099115A3 Nucleic acid-associated proteins |
11/13/2003 | WO2002067956A3 Method for purifying a biological composition |
11/13/2003 | WO2002066648A3 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
11/13/2003 | WO2002057226A8 68730 and 69112 protein kinase molecules and uses therefor |
11/13/2003 | US20030212266 Growth arrest homeobox gene |
11/13/2003 | US20030212141 Serotonin antagonists |
11/13/2003 | US20030212138 Synergistic mixture; analgesics, antiinflammatory agents, cardiovascular disorders, anticancer agents |
11/13/2003 | US20030212117 Efficient process for the preparation of a factor Xa inhibitor |
11/13/2003 | US20030212093 Imidazonaphthyridines |
11/13/2003 | US20030212091 Aryl ether substituted imidazoquinolines |
11/13/2003 | US20030212073 Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof |
11/13/2003 | US20030212071 Controlling blood coagulation |
11/13/2003 | US20030212069 Antithrombotic amides |
11/13/2003 | US20030212064 Triazolotriazinones and the use thereof |
11/13/2003 | US20030212054 Therapy, prevention thrombosis; anticoagulant |
11/13/2003 | US20030212042 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
11/13/2003 | US20030212030 Blood disorders; synergistic mixture of vector and monoclonal antibody |
11/13/2003 | US20030212012 Prevention labor contraction; urogenital disorders |
11/13/2003 | US20030211986 Protein a compositions and methods of use |
11/13/2003 | US20030211969 Administering activated protein c; controlling blood coagulation |
11/13/2003 | US20030211513 Intracellular signaling proteins |
11/13/2003 | US20030211103 Use of primate IFN-gamma binding molecules |
11/13/2003 | US20030211077 Stimulanting hematopoiesis |
11/13/2003 | CA2491708A1 Non-viral gene delivery system |
11/13/2003 | CA2485116A1 Use of epa and dha in secondary prevention |
11/13/2003 | CA2485086A1 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes |
11/13/2003 | CA2485065A1 Semicarbazide derivatives for combating thromboembolic diseases |
11/13/2003 | CA2484874A1 Monocompartment osmotic controlled drug delivery system |
11/13/2003 | CA2484551A1 Smart pro-drugs of serine protease inhibitors |
11/13/2003 | CA2484209A1 Protein kinase modulators and methods of use |
11/13/2003 | CA2484173A1 4-azasteroid derivatives as androgen receptor modulators |